Banka Bioloo Ltd vs Genomic Valley Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 22, 2026

Key Highlights

The Latest Trading Price of Banka Bioloo Ltd is ₹ 66.1 as of 22 Oct 15:30 . The P/E Ratio of Banka Bioloo Ltd changed from 27.9 on March 2021 to 131.2 on March 2026 . This represents a CAGR of 29.44% over 6 yearsThe P/E Ratio of Genomic Valley Biotech Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Banka Bioloo Ltd changed from ₹ 61.43 crore on March 2021 to ₹ 45.84 crore on March 2026 . This represents a CAGR of -4.76% over 6 yearsThe Market Cap of Genomic Valley Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Banka Bioloo Ltd for the Jun '26 is ₹ 10.66 crore as compare to the Mar '26 revenue of ₹ 17.81 crore. This represent the decline of -40.15% The revenue of Genomic Valley Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Banka Bioloo Ltd for the Jun '26 is ₹ 1.92 crore as compare to the Mar '26 ebitda of ₹ 3.19 crore. This represent the decline of -39.81% The ebitda of Genomic Valley Biotech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Banka Bioloo Ltd changed from ₹ 0.29 crore to ₹ -0.04 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Banka Bioloo Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Banka Bioloo Ltd

Banka Bioloo Limited was incorporated as a Private Limited company as 'Banka Bioloo Private Limited' on August 31, 2012.
It changed the status to Public Limited Company with effect from November 15, 2017.
Company was incorporated with the main object to provide sanitation infrastructure and hygienic solutions for human waste treatment and disposal.
After receiving the Certificate of Incorporation, the Company took over the running business of the Promoter- Banka Enterprises', a sole proprietorship through a Business Takeover Agreement dated Feb. 1, 2013. The Company is engaged in the activities of sanitation, fecal sludge, sewage and wastewater treatment plants.
It provides sanitation infrastructure and human waste management solutions and services, involving innovative and simple biodigester technology patented by Defence Research and Development Organisation (DRDO), the R&D arm of the Indian Ministry of Defence.

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses, NFT & DFT etc, manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

FAQs for the comparison of Banka Bioloo Ltd and Genomic Valley Biotech Ltd

Which company has a larger market capitalization, Banka Bioloo Ltd or Genomic Valley Biotech Ltd?

Market cap of Banka Bioloo Ltd is 72 Cr while Market cap of Genomic Valley Biotech Ltd is 10 Cr

What are the key factors driving the stock performance of Banka Bioloo Ltd and Genomic Valley Biotech Ltd?

The stock performance of Banka Bioloo Ltd and Genomic Valley Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Banka Bioloo Ltd and Genomic Valley Biotech Ltd?

As of October 22, 2026, the Banka Bioloo Ltd stock price is INR ₹66.1. On the other hand, Genomic Valley Biotech Ltd stock price is INR ₹35.92.

How do dividend payouts of Banka Bioloo Ltd and Genomic Valley Biotech Ltd compare?

To compare the dividend payouts of Banka Bioloo Ltd and Genomic Valley Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.